| Literature DB >> 27339589 |
Faruque Pathan1, Zafar Ahmed Latif2, Rakesh Kumar Sahay3, Abdul Hamid Zargar4, Syed Abbas Raza5, Azad Khan6, Nazrul Islam Siddiqui7, Feroz Amin7, Noel Somasundaram8, Dina Shrestha9, Sanjay Kalra1.
Abstract
This guidance is an update to the South Asian Consensus Guideline: Use of GLP1RA in Diabetes during Ramadan, published in the Indian Journal of Endocrinology and Metabolism in 2012. A five country working group has collated evidence and experience to suggest guidelines for the safe and rational use of glucagon-like peptide1 receptor agonists during Ramadan. The suggestions contained herewith are based upon recently published evidence as well as available basic pharmacological data.Entities:
Keywords: Dulaglutide, Exenatide QW, GLP1RA, Hypoglycaemia, Liraglutide, Lixisenatide, Ramadan, South Asia.
Mesh：
Substances：
Year: 2016 PMID： 27339589
Source DB: PubMed Journal: J Pak Med Assoc ISSN： 0030-9982 Impact factor: 0.781